Corbus Pharmaceuticals Holdings, Inc.
CRBP
$10.03
$0.141.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.95M | -50.29M | -40.21M | -38.70M | -34.97M |
| Total Depreciation and Amortization | 420.00K | 517.00K | 588.00K | 602.00K | 603.00K |
| Total Amortization of Deferred Charges | 76.00K | 208.00K | 396.00K | 586.00K | 714.00K |
| Total Other Non-Cash Items | 5.01M | 4.41M | 3.01M | 2.69M | 1.74M |
| Change in Net Operating Assets | -5.46M | -5.09M | -5.58M | -2.04M | 1.82M |
| Cash from Operations | -57.90M | -50.25M | -41.79M | -36.86M | -30.09M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.23M | -4.95M | -121.31M | -119.65M | -93.39M |
| Cash from Investing | 29.23M | -4.95M | -121.31M | -119.65M | -93.39M |
| Total Debt Issued | -- | -- | -- | 373.00K | 373.00K |
| Total Debt Repaid | -10.90M | -13.16M | -15.48M | -17.68M | -7.53M |
| Issuance of Common Stock | 35.94M | 73.17M | 182.07M | 182.07M | 146.13M |
| Repurchase of Common Stock | -13.00K | -13.00K | -13.00K | -74.00K | -154.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.03M | 60.00M | 166.58M | 164.69M | 138.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.64M | 4.80M | 3.47M | 8.17M | 15.34M |